Cervical cancer chemo easier on black women: study
NEW YORK (Reuters Health) - Black women with advanced and recurrent cervical cancer tolerate “platinum-based” chemotherapy drugs better than do their white counterparts, according to a pooled data from three studies, researchers report.
Dr. Steven C. Plaxe of the University of California, San Diego and colleagues examined data on a total of 374 white and 125 black women who were treated with a variety of chemotherapy drug combinations that included cisplatin — a platinum-based drug commonly used to fight various cancers.
The researchers found that black women had significantly less moderate to severe neutropenia (63 percent) than did whites (82 percent). Neutropenia is a condition characterized by a drop in a particular type of infection-fighting white blood cell called the neutrophil that can occur with frequent chemotherapy.
Two other chemotherapy-related side effects — leukopenia (an abnormally low white blood cell count) and thrombocytopenia (a reduction in blood clotting platelet cells) were also less common in black women than in white women.
Moreover, compared to white women, black women were not at increased risk of having their disease get worse or of dying from their disease, the study team reports in the American Journal of Obstetrics and Gynecology.
“Our results,” Plaxe told Reuters Health, “support efforts directed at encouraging enrollment of all eligible women, particularly minorities, into clinical research studies.”
SOURCE: American Journal of Obstetrics and Gynecology, November 2008.
--------------------------------------------------------------------------------------------Related Posts:
NEW YORK (Reuters Health) - Women and girls who’ve had an unplanned pregnancy in the past are at risk of future unplanned pregnancies, regardless of other risk factors like age and education, a new study shows. Researchers found that of 542 women and teenage girls enrolled in a study to encourage contraceptive use, those with a
Full Post: Unintended pregnancy raises risk of future ones
--------------------------------------------------------------------------------------------
By Amy Norton NEW YORK (Reuters Health) - Taking a walk instead of turning on the TV may help African-American women lower their risk of type 2 diabetes, a large study suggests. Researchers found that among more than 45,000 African-American women they followed for a decade, those who said they walked for exercise at least five hours
Full Post: More exercise may prevent diabetes in black women
--------------------------------------------------------------------------------------------
By Amy Norton NEW YORK (Reuters Health) - Close to half of U.S. women report some form of sexual difficulty, but far fewer are distressed about their problem, a new study suggests. In a survey of more than 31,000 U.S. women, researchers found that 44 percent said they had some problem with their sexual function, including low
Full Post: Many women not upset by sexual problems: study
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Older African-American, Native American and non-white Hispanic women are more likely to develop arthritis than their white counterparts, and the larger prevalence of obesity among these ethnic groups may help explain why, new research shows. Among 146,494 women participating in the Women’s Health Initiative — an ongoing study of an ethnically
Full Post: Ethnic differences in arthritis due to obesity
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - The odds are high that a woman who is prescribed an “anticholinergic” drug to relieve urinary incontinence or other lower urinary tract symptom will discontinue the medication not long after starting it, a study suggests. This is true regardless of the class of medication used. Two examples of anticholinergic drugs that
Full Post: Drug adherence poor in women with urinary trouble